MYND Life Sciences Inc
CNSX:MYND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
I
|
Indika Energy Tbk PT
SWB:I41
|
ID |
|
H
|
Harley-Davidson Inc
DUS:HAR
|
US |
|
A
|
Ashmore Group PLC
F:A1B
|
UK |
|
N
|
Nusantara Inti Corpora Tbk PT
IDX:UNIT
|
ID |
|
E
|
Edenred SE
XMUN:QSV
|
FR |
Intrinsic Value
Is MYND undervalued or overvalued?
See the intrinsic value estimate for MYND Life Sciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MYND looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MYND’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What MYND Life Sciences Does
MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. The firm is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The firm is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications of Psilocybins for overcoming disease. The firm is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.
- Headquarters
- Canada CA
- IPO date
- May 26, 2021
Earnings Waterfall
MYND Life Sciences Inc
The intrinsic value for MYND Life Sciences Inc (MYND) under the Base Case is hidden CAD.
Compared with the current market price of 0.07 CAD, the stock appears hidden.